You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
McKesson
Johnson and Johnson
Colorcon
Harvard Business School

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 5,496,554

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,496,554
Title: Purified mite allergen
Abstract:New purified mite allergens useful as pharmaceutical and diagnostic compositions for the treatment and diagnosis of mite allergic diseases are provided. Both allergens are contained in fecal extracts of mites in culture. The high molecular weight allergen has a weight average molecular weight of 70,000 to 80,000 as determined by sedimentation equilibrium. This is a glycoprotein containing more than about 70% sugar, and possesses allergen activity. The low molecular weight antigen has a molecular weight of 1,500 to 5,000 as determined by Sephadex G25 gel filtration. This is a glycoprotein containing more than about 40% sugar, and also possesses allergen activity.
Inventor(s): Oka; Satoru (Hiroshima, JP), Ono; Kazuhisa (Hiroshima, JP), Shigeta; Seiko (Hiroshima, JP), Wada; Takeshi (Hiroshima, JP)
Assignee: Fumakilla Limited (Tokyo, JP) Hiroshima University (Hiroshima, JP)
Application Number:08/283,905
Patent Claims:see list of patent claims

Details for Patent 5,496,554

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Greer Laboratories, Inc. STANDARDIZED MITE DERMATOPHAGOIDES FARINAE dermatophagoides farinae CONCENTRATE 101834 1 2010-02-03   Start Trial Fumakilla Limited (Tokyo, JP) Hiroshima University (Hiroshima, JP) 2013-03-05 search
Greer Laboratories, Inc. STANDARDIZED MITE DERMATOPHAGOIDES PTERONYSSINUS dermatophagoides pteronyssinus CONCENTRATE 101835 1 2010-02-03   Start Trial Fumakilla Limited (Tokyo, JP) Hiroshima University (Hiroshima, JP) 2013-03-05 search
Jubilant Hollisterstier Llc POSITIVE SKIN TEST CONTROL - HISTAMINE histamine INJECTION 103891 1 1995-06-15   Start Trial Fumakilla Limited (Tokyo, JP) Hiroshima University (Hiroshima, JP) 2013-03-05 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKinsey
Dow
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.